Chapter 1 Evolution of Non-invasive Prenatal Screening (NIPS) Past to Present.- Chapter 2 Fetal origin circulating cell-free nucleic acids (cfNA) in maternal circulation and their clinical importance in fetal diagnosis.- Chapter 3 Cell-free fetal DNA (cffDNA): Genesis to clinical utility.- Chapter 4 Methods and protocols for extraction of cell-free fetal DNA (cffDNA) from the maternal circulation.- Chapter 5 Scope of cell- versus cell-free -based detection approach in Non-invasive Prenatal Screening (NIPS).- Chapter 6 Advanced genomic approaches in Non-invasive Prenatal Screening (NIPS) The road from conventional Karyotyping to Next-Gen Sequencing (NGS).- Chapter 7 Proteomic biomarkers of maternal plasma and their use in Non-invasive Prenatal Testing (NIPT).- Chapter 8 Non-invasive Prenatal Screening (NIPS) of chromosomal abnormalities.
- Chapter 9 Non-invasive Prenatal Detection (NIPD) of fetal sex and RhD blood type.- Chapter 10 Detection of monogenic disorders using Non-invasive Prenatal Screening (NIPS).- Chapter 11 Screening of Placental dysfunction utilizing cell-free nucleic acids (cfNA) of maternal plasma.- Chapter 12 Non-invasive Prenatal Detection (NIPD) of Copy number variation (CNV) and sub-chromosomal variations.- Chapter 13 Circulation transcriptome of maternal plasma and its use in Non-invasive Prenatal Screening (NIPS).- Chapter 14 Challenges and ethical issues surrounding Non-invasive Prenatal Screening (NIPS).- Chapter 15 Implementation of Non-invasive Prenatal Screening (NIPS) in clinical practice: Comparison of developed versus developing countries.- Chapter 16 Sequencing: A promising path in the detection of fetal health.